If a company builds assets at 50.7% a year, faster than its revenue growth rate of 33.1% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Guangdong Hybribio Biotech Co's average Total Assets Growth Rate was -10.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 42.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 50.70% per year.
During the past 10 years, the average Total Assets Growth Rate was 39.40% per year.
During the past 12 years, Guangdong Hybribio Biotech Co's highest 3-Year average Total Assets Growth Rate was 72.70%. The lowest was 21.50%. And the median was 45.30%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Hybribio Biotech Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Hybribio Biotech Co (SZSE:300639) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Guangdong Hybribio Biotech Co's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Guangdong Hybribio Biotech Co Total Assets Related Terms
Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Guangdong Hybribio Biotech Co (SZSE:300639) Business Description
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Guangdong Hybribio Biotech Co (SZSE:300639) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300639 has been successfully added to your 